Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Casali
Relationship Between Socioeconomic Factors and Delay in Diagnosis and Initial Treatment in Patients With Difusse Large B Cell Lymphoma (Dlbcl). Do These Factors Impact on the Response Rate? Results of a Multicentric Argentinian Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Biomarkers of Diffuse Large B-Cell Lymphoma: Impact on Diagnosis, Treatment, and Prognosis
Current Biomarker Findings
Biochemistry
Clinical Biochemistry
Simultaneous Diffuse Large B-Cell Lymphoma (Dlbcl) and Follicular Lymphoma (Fl) at the Diagnosis Has Similar Outcome as DLBCL
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Analysis Results of the Regional Registry of Patients With Diffuse Large B-Cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Antiviral Therapy and Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) With Hepatitis C (Hcv)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Impaired Immune Health in Survivors of Diffuse Large B-Cell Lymphoma (Dlbcl): A Large Population-Based Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Prevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients With Diffuse Large B-Cell Lymphoma (DLBCL): A Case-Control Study
PLoS ONE
Multidisciplinary
A Case Report of Unusually Long Lag Time Between Immunotactoid Glomerulopathy (Itg) Diagnosis and Diffuse Large B-Cell Lymphoma (DLBCL) Development
BMC Nephrology
Nephrology
Unfavorable Prognostic Impact of MYC Increased Copy Number (ICN) in Patients With Diffuse Large B-Cell (DLBCL) and High-Grade Lymphoma Treated With Immunochemotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Response of Diffuse Large B-Cell Lymphoma Treated With R-Chop and Prognostic Factors Associated: A Single Institution Analysis in Lima, Peru
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
